Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic

This publication has 37 references indexed in Scilit:

• Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
  Calcified Tissue International, 2011
• Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor‐dependent osteoblastic functions in UMR 106 cells
  British Journal of Pharmacology, 2010
• Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
  Mayo Clinic Proceedings, 2009
• Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro
  Life Sciences, 2007
• The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
  Trends in Immunology, 2007
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  Cytotherapy, 2006
• Osteoclast differentiation and activation
  Nature, 2003
• Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro
  Journal of Bone and Mineral Research, 1998
• Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha.
  Proceedings of the National Academy of Sciences, 1995
• Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
  Cell, 1994